1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9980):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-A0132S12
    N-Acetyl-D-glucosamine-13C6
    N-Acetyl-D-glucosamine-13C6 (N-Acetyl-2-amino-2-deoxy-D-glucose-13C6) is the 13C labled N-Acetyl-D-glucosamine (HY-A0132). N-Acetyl-D-Glucosamine (N-Acetyl-2-amino-2-deoxy-D-glucose) is a monosaccharide derivative of glucose.
    N-Acetyl-D-glucosamine-<sup>13</sup>C<sub>6</sub>
  • HY-135328AS
    Norverapamil-d7 hydrochloride
    98.77%
    Norverapamil-d7 (hydrochloride) is a deuterium labeled Norverapamil. Norverapamil ((±)-Norverapamil), an N-demethylated metabolite of Verapamil, is a L-type calcium channel blocker and a P-glycoprotein (P-gp) function inhibitor.
    Norverapamil-d<sub>7</sub> hydrochloride
  • HY-13771S1
    Ursodeoxycholic acid-13C
    Ursodeoxycholic acid-13C is the 13C labeled Ursodeoxycholic acid. Ursodeoxycholic acid (Ursodeoxycholate) is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. Ursodeoxycholic acid acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors, including G-protein coupled bile acid receptor 5 (TGR5, GPCR19) and the farnesoid X receptor (FXR). Ursodeoxycholic acid can be used for the research of a variety of hepatic and gastrointestinal diseases. Orally active.
    Ursodeoxycholic acid-<sup>13</sup>C
  • HY-W705406
    3-Carboxy Detomidine Methyl Ester-15N2
    3-Carboxy Detomidine Methyl Ester-15N2 is the 15N labeled 3-Carboxy Detomidine Methyl Ester.
    3-Carboxy Detomidine Methyl Ester-<sup>15</sup>N<sub>2</sub>
  • HY-W707562
    FOY 251-d4
    FOY 251-d4 is the deuterium labeled FOY 251 (HY-19727A). FOY 251, an anti-proteolytic active metabolite Camostate (HY-13512), acts as a proteinase inhibitor. FOY 251 inhibits SARS-CoV-2 infection in cells assay.
    FOY 251-d<sub>4</sub>
  • HY-W011683S3
    2'-Deoxyadenosine monohydrate-5′-13C
    2'-Deoxyadenosine monohydrate-5′-13C is the 13C labeled 2'-Deoxyadenosine monohydrate (HY-W011683). 2′-Deoxyadenosine monohydrate is an adenine nucleoside that inhibits glucose-stimulated insulin release. 2′-Deoxyadenosine monohydrate inhibits glucose-stimulated increases seen in islet cyclic AMP (cAMP) accumulation. 2'-Deoxyadenosine monohydrate activates caspase-3 and promotes apoptosis. 2'-Deoxyadenosine monohydrate inhibits the activity of S-adenosyl-L-homocysteine hydrolase (SAHH). 2'-Deoxyadenosine monohydrate inhibits the growth of various cells. 2'-Deoxyadenosine monohydrate has an anticancer effect on colon cancer.
    2'-Deoxyadenosine monohydrate-5′-<sup>13</sup>C
  • HY-W710425
    N-(Methyl-d3)-5-nitroquinolin-6-amine
    N-(Methyl-d3)-5-nitroquinolin-6-amine is the deuterium labeled N-methyl-5-nitroquinolin-6-amine (HY-W334909).
    N-(Methyl-d<sub>3</sub>)-5-nitroquinolin-6-amine
  • HY-B0153AS
    Ticlopidine-d4 hydrochloride
    Ticlopidine-d4 (hydrochloride) is the deuterium labeled Ticlopidine hydrochloride. Ticlopidine hydrochloride is an adenosine diphosphate (ADP) receptor inhibitor against platelet aggregation with IC50 of ~2 μM.
    Ticlopidine-d<sub>4</sub> hydrochloride
  • HY-W097453S1
    6-(Methylthio)purine-d3
    6-(Methylthio)purine3 is the deuterium labeled 6-(Methylthio)purine.
    6-(Methylthio)purine-d<sub>3</sub>
  • HY-13632S1
    Exemestane-13C3
    Exemestane-13C3 is the 13C-labeled Exemestane. Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research.
    Exemestane-<sup>13</sup>C<sub>3</sub>
  • HY-B0648S1
    Medroxyprogesterone-d7
    Medroxyprogesterone-d7 is deuterium labeled Medroxyprogesterone.
    Medroxyprogesterone-d<sub>7</sub>
  • HY-B0473S
    Tetracaine-d6 hydrochloride
    Tetracaine-d6 (hydrochloride) is the deuterium labeled Tetracaine hydrochloride.
    Tetracaine-d<sub>6</sub> hydrochloride
  • HY-17509S
    Deracoxib-d3
    Deracoxib-d3 (SC 046-d3; SC 59046-d3) is the deuterium labeled Deracoxib (HY-17509). Deracoxib, an orally active COX-2 inhibitor, is a veterinary nonsteroidal anti-inflammatory agent used exclusively in dogs. Deracoxib inhibits the COX-2 enzyme to reduce the production of prostaglandins, effectively controlling pain and inflammation after canine soft tissue surgery. Deracoxib reduces the inhibition of COX-1 and lowers the risk of gastrointestinal side effects. Deracoxib induces tumor cell cycle arrest and apoptosis, and shows anti-tumor activity in canine osteosarcoma, breast tumors and bladder transitional cell carcinomas.
    Deracoxib-d<sub>3</sub>
  • HY-W353946S
    Mono-iso-Propyl Phthalate-3,4,5,6-d4
    Mono-iso-Propyl Phthalate-3,4,5,6-d4 is the deuterium labeled Mono-iso-Propyl Phthalate.
    Mono-iso-Propyl Phthalate-3,4,5,6-d<sub>4</sub>
  • HY-W778297
    5,6-Diamino-4-thiouracil-13C2
    5,6-Diamino-4-thiouracil-13C2 is the 13C-labeled 5,6-Diamino-4-thiouracil (HY-W740396).
    5,6-Diamino-4-thiouracil-<sup>13</sup>C<sub>2</sub>
  • HY-W777099
    N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly[13C2,15N]-OBzl
    N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly[13C2,15N]-OBzl is the 13C- and 15N-labeled N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly-OBzl.
    N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly[<sup>13</sup>C<sub>2</sub>,<sup>15</sup>N]-OBzl
  • HY-W743774
    gamma-Cyhalothrin-(phenoxy-d5)
    gamma-Cyhalothrin-(phenoxy-d55) is a deuterated labeled gamma-Cyhalothrin-(phenoxy).
    gamma-Cyhalothrin-(phenoxy-d<sub>5</sub>)
  • HY-W097055S
    2-(2-Formamidothiazol-4-yl)acetic acid-13C,15N2
    2-(2-Formamidothiazol-4-yl)acetic acid-13C,15N2 (2-Formamidothiazol-4-acetic acid-13C,15N2) is the 13C- and 15N-labeled 2-(2-Formamidothiazol-4-yl)acetic acid (HY-W097055).
    2-(2-Formamidothiazol-4-yl)acetic acid-<sup>13</sup>C,<sup>15</sup>N<sub>2</sub>
  • HY-33549S
    DL-Metirosine-13C,d3 hydrochloride
    DL-Metirosine-13C,d3 (hydrochloride) is deuterium labeled α-Methyl-p-tyrosine.
    DL-Metirosine-<sup>13</sup>C,d<sub>3</sub> hydrochloride
  • HY-W720448
    VR23-d8
    VR23-d8 is the deuterium labeled VR23 (HY-18741). VR23 is a small molecule that potently inhibits the activities of trypsin-like proteasomes (IC50=1 nM), chymotrypsin-like proteasomes (IC50=50-100 nM), and caspase-like proteasomes (IC50=3 μM).
    VR23-d<sub>8</sub>